Professor, UW Medicine/Allergy and Infectious Diseases
Adjunct Professor of Pharmacology
Yale University, Postdoctoral Fellow 1980-1983
MD, University of Rochester 1977
BS, Brooklyn College, 1973
High throughput technologies to reverse engineer disease epigenetic pathways as a way to discover disease biomarkers and drug targets.
The Bomsztyk lab is developing high throughput methods, technologies and computational tools to reverse engineer epigenetic alterations of disease such as cancer, organ injury, sepsis and others. The goal is to use these user-friendly technologies to identify disease epigenetic alteration, biomarkers and druggable targets for precision medicine.